Skip to main content

Table 1 State prevalence and transition probability matrix for anti-malarial treatments used before and during pregnancy

From: Is there a distinction between malaria treatment and intermittent preventive treatment? Insights from a cross-sectional study of anti-malarial drug use among Ugandan pregnant women

 

State prevalences (%) n=330

Transition probabilities

 

Before pregnancy

During pregnancy

→ ACT/QNN

→ Others

→ SP

ACT/QNN →

74.5

41.9

0.451

0.085

0.463

Others →

12.1

7.9

0.425

0.025

0.550

SP →

13.3

51.2

0.159

0.091

0.750